These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8136611)

  • 1. Increased fMet-Leu-Phe receptor expression and altered superoxide production of neutrophil granulocytes in septic and posttraumatic patients.
    Tschaikowsky K; Sittl R; Braun GG; Hering W; Rügheimer E
    Clin Investig; 1993 Dec; 72(1):18-25. PubMed ID: 8136611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-phenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera.
    Samuelsson J; Hansson A; Rosendahl K; Palmblad J
    J Lab Clin Med; 1993 Feb; 121(2):310-9. PubMed ID: 8381848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil activation in sepsis. The relationship between fmet-leu-phe receptor mobilization and oxidative activity.
    Tennenberg SD; Solomkin JS
    Arch Surg; 1988 Feb; 123(2):171-5. PubMed ID: 2829789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
    J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor and non-receptor mediated formation of superoxide anion and hydrogen peroxide in neutrophils of intensive care patients.
    Manhart N; Oismüller C; Lassnig A; Spittler A; Sautner T; Götzinger P; Függer R; Roth E
    Wien Klin Wochenschr; 1998 Nov; 110(22):796-801. PubMed ID: 9885146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of the colonic milieu on neutrophil oxidative burst: a possible pathogenic mechanism of ulcerative colitis.
    Keshavarzian A; Haydek JM; Jacyno M; Holmes EW; Harford F
    J Lab Clin Med; 1997 Aug; 130(2):216-25. PubMed ID: 9280150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils.
    Kim CD; Hong KW
    J Pharmacol Exp Ther; 1997 Apr; 281(1):478-83. PubMed ID: 9103534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute ethanol intoxication regulates f-met-leu-phe-induced chemotaxis and superoxide release by neutrophils and Kupffer cells through modulation of the formyl peptide receptor in the rat.
    Bautista AP; Elliott KE
    Life Sci; 1994; 54(11):721-30. PubMed ID: 8107522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.
    Stenson WF; Mehta J; Spilberg I
    Biochem Pharmacol; 1984 Feb; 33(3):407-12. PubMed ID: 6142713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils.
    Yamamoto Y; Kanazawa T; Shimamura M; Ueki M; Hazato T
    Biochem Pharmacol; 1997 Sep; 54(6):695-701. PubMed ID: 9310346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface expression of fMet-Leu-Phe receptors on human neutrophils. Correlation to changes in the cytosolic free Ca2+ level and action of phorbol myristate acetate.
    Andersson T; Dahlgren C; Lew PD; Stendahl O
    J Clin Invest; 1987 Apr; 79(4):1226-33. PubMed ID: 3558823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity.
    Kaufmann I; Hoelzl A; Schliephake F; Hummel T; Chouker A; Peter K; Thiel M
    Shock; 2006 Sep; 26(3):254-61. PubMed ID: 16912650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
    Fletcher MP; Stahl GL; Longhurst JC
    J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-cytoskeleton interactions and membrane traffic may regulate chemoattractant-induced superoxide production in human granulocytes.
    Jesaitis AJ; Tolley JO; Allen RA
    J Biol Chem; 1986 Oct; 261(29):13662-9. PubMed ID: 3020040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
    Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils.
    Atkinson YH; Lopez AF; Marasco WA; Lucas CM; Wong GG; Burns GF; Vadas MA
    Immunology; 1988 Jul; 64(3):519-25. PubMed ID: 2842255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L; Aksamit RR
    J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of N-acetylcysteine on superoxide anion generation in human polymorphonuclear leukocytes.
    Villagrasa V; Cortijo J; Martí-Cabrera M; Ortiz JL; Berto L; Esteras A; Bruseghini L; Morcillo EJ
    J Pharm Pharmacol; 1997 May; 49(5):525-9. PubMed ID: 9178189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the priming effect of phorbol myristate acetate and phorbol dibutyrate on fMet-Leu-Phe-induced oxidative burst in human neutrophils.
    Gaudry M; Combadiere C; Marquetty C; Hakim J
    Immunopharmacology; 1990; 20(1):45-56. PubMed ID: 2172183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.